Heart, Lung and Circulation
Volume 16, Issue 4 , Pages 274-281 , August 2007

Myocardial Release of Nitric Oxide During Ischaemia and Reperfusion: Effects of l-Arginine and Hypercholesterolaemia

  • Ananth M. Prasan, MBBS, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Cardiology, Level 1 Clinical Services Building, St George Hospital, Gray Street, Kogarah, New South Wales 2217, Australia. Tel.: +612 93503165; fax: +612 95474107.
    • ,
  • Hugh C.K. McCarron, BSc, PhD
    • ,
  • Yi Zhang, MBBS, PhD
    • ,
  • Richmond W. Jeremy, MBBS, PhD

Received 24 October 2006 ,Revised 13 February 2007 ,Accepted 14 February 2007.

References 

  1. Abu-Soud HM, Ichimori K, Presta A, Stuehr DJ. Electron transfer, oxygen binding, and nitric oxide feedback inhibition in endothelial nitric-oxide synthase. J Biol Chem. 2000;275:17349–17357
  2. Aulak KS, Miyagi M, Yan L, West KA, Massillon D, Crabb JW, et al. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. PNAS. 2001;98:12056–12061
  3. Baydoun AR, Emery PW, Pearson JD, Mann GE. Substrate-dependent regulation on intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochem Biophys Res Commun. 1990;173:943–948
  4. Boger RH, Bode-Boger SM, Mugge A, Kienke S, Brandes R, Dwenger A, et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 1995;117:273–284
  5. Bolli R, Jeroudi MO, Phatel BS, Aruoma AI, Halliwell B, Lai EK, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury. Circ Res. 1989;65:607–622
  6. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79:609–634
  7. Brovkovych V, Dobrucki LW, Brovkovych S, Dobrucki I, Do Nascimento CA, Burewicz A, et al. Direct electrochemical measurement of nitric oxide in vascular endothelium. J Physiol Pharmacol. 1999;50:575–586
  8. Creager MA, Cooke JP, Mendelson ME, Gallagher SJ, Coleman SM, Loscalzo J, et al. Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228–234
  9. Csonka C, Szilvassy Z, Fulop F, Pali T, Blasig IE, Tosaki A, et al. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation. 1999;100:2260–2266
  10. Depre C, Fierain L, Hue L. Activation of nitric oxide synthase by ischaemia in the perfused heart. Cardiovasc Res. 1997;33:82–87
  11. Depre C, Vanoverschelde J-L, Goudemant J-F, Mottet I, Hue L. Protection against ischaemic injury by non-vasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation. 1995;92:1911–1918
  12. Drexler H, Zeiher AM, Menzer K, Just H. Correction of endothelial dysfunction in the coronary microvasculature of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546–1550
  13. Engelman DT, Watanabe M, Maulik N, Cordis GA, Engelman RM, Rousou JA, et al. L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg. 1995;60:1275–1281
  14. Ferdinandy P, Szilvassy Z, Horvath LI, Csont T, Csonka C, Nagy E, et al. Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol. 1997;29:3321–3333
  15. Hecker M, Mitchell JA, Harris HJ, Katsura M, Thiemermann C, Vane JR. Endothelial cells metabolise NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Commun. 1990;167:1037–1043
  16. Huk I, Nanobashvilli J, Neumayer C, Punz A, Mueller M, Afkhampour K, et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation. 1997;96:667–675
  17. Jeremy RW, McCarron H, Sullivan D. Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolaemic rabbit. Response according to treatment duration, anatomic site and sex. Circulation. 1996;94:498–506
  18. Kuo L, Davis MJ, Cannon MS, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine. Circ Res. 1992;70:456–476
  19. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90min ischemia. Circulation. 1989;80:1816–1827
  20. Maulik N, Engelman DT, Watanabe M, Engelman RM, Maulik G, Cordis GA, et al. Nitric oxide signaling in ischemic heart. Cardiovasc Res. 1995;30:593–601
  21. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104:174–180
  22. Mori E, Haramaki N, Ikeda H, Imaizumi T. Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs. Cardiovasc Res. 1998;34:113–123
  23. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Luscher TF. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation. 1998;97:2494–2498
  24. Pabla R, Curtis MJ. Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species dependence in the rat versus rabbit isolated heart. J Mol Cell Cardiol. 1996;28:2097–2110
  25. Pernow J, Uriuda Y, Wang Q-D, Li X-S, Nordlander R, Rydeen L. The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig. Eur Heart J. 1994;15:1712–1719
  26. Peterson TE, Poppa V, Ueba H, Wu A, Yan C, Berk BC. Opposing effects of reactive oxygen species and cholesterol on endothelial cell nitric oxide synthase and endothelial cell caveolae. Circ Res. 1999;85:29–37
  27. Prasan AM, McCarron HCK, Hambly BD, Fermanis GG, Sullivan DR, Jeremy RW. Effect of treatment on ventricular function and troponin I proteolysis in reperfused myocardium. J Mol Cell Cardiol. 2002;34:401–411
  28. Pritchard KA, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res. 1995;77:510–518
  29. Privat C, Lantoine F, Bedioui F, Millanvoye van Brussel E, Devynck J, Devynck MA. Nitric oxide production by endothelial cells: comparison of three methods of quantification. Life Sci. 1997;61:1193–1202
  30. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res. 1995;30:432–439
  31. SPSS, Version 8.0. Chicago, Ill.: SPSS, Inc.; 1998.
  32. Stevens RM, Jahania MS, Stivers JE, Mentzer RM, Lasley RD. Effects of in vivo myocardial ischemia and reperfusion on interstitial nitric oxide metabolites. Ann Thorac Surg. 2002;73:1261–1266
  33. Stuehr DJ, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem. 2001;276:14533–14536
  34. Takano H, Manchikalapudi S, Tang X-L, Qiu Y, Rizvi A, Jadoon AK, et al. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation. 1998;98:441–449
  35. Takeuchi K, McGowan FX, Danh HC, Glynn P, Simplanceanu E, del Nido PJ. Direct detrimental effects of L-arginine upon ischemia-reperfusion injury to myocardium. J Mol Cell Cardiol. 1995;27:1405–1414
  36. Taniguchi I, Kobayashi M, Date T, Taniguchi M, Mochizuki S . Role of oxygen in nitric oxide release on hypoxia-reoxygenation injury in isolated perfused rat hearts. In:  Moncarda S editors. Biology of nitric oxide. London: Portland Press; 1998;p. 223
  37. Vergnani L, Hatrik S, Ricci F, Passaro A, Manzoli N, Zuliani G, et al. Effect of native and oxidised low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of L-arginine availability. Circulation. 2000;101:1261–1266
  38. Wahida Y, Strynadka KD, Schulz R. Generation of peroxynitrite contributes to ischaemia-reperfusion injury in isolated rat hearts. Cardiovasc Res. 1997;33:422–432
  39. Wang Q, Morcos E, Wiklund P, Pernow J. L-arginine enhances functional recovery and Ca2+-dependent nitric oxide synthase activity after ischemia and reperfusion in the rat heart. J Cardiovasc Pharmacol. 1997;29:291–296
  40. Wascher TC, Posch K, Wallner S, Hermetter A, Kostner GM, Graier WF. Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase?. Biochem Biophys Res Commun. 1997;234:35–38
  41. Wever RMF, Lusher TF, Cosentino T, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 1998;97:108–112
  42. Weyrich AS, Ma XI, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 1992;79:279–288
  43. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 1987;84:1404–1407
  44. Zweier JL, Wang P, Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem. 1995;270:304–307
  45. Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med. 1995;1:804–809
  46. Woditsch I, Schror K. Reduced endothelium-dependent relaxation at enhanced NO release in hearts of hypercholesterolemic rabbits. Br J Pharmacol. 1994;111(4):1035–1040

PII: S1443-9506(07)00133-3

doi: 10.1016/j.hlc.2007.02.092

Heart, Lung and Circulation
Volume 16, Issue 4 , Pages 274-281 , August 2007

Article Tools

* Image Usage & Resolution